Milestone Scientific Inc. (MLSS)

CIK 0000855683 · Healthcare · Medical Instruments & Supplies

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
FY-2025
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —
Q2-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Document and Entity Information
Statements
Condensed Consolidated Balance Sheets (current Period Unaudited)
—
Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (current Period Unaudited) (P)
—
Consolidated Balance Sheets (P)
Consolidated Consolidated Statements of Operations (unaudited)
—
Consolidated Statements of Operations
Consolidated Statements of Changes In Stockholders' Equity
Consolidated Statements of Cash Flows
Consolidated Statements of Changes In Stockholders' Equity (P)
Consolidated Consolidated Statements of Cash Flows (unaudited)
—
Notes
Advances On Contracts
Benefit Plan
—
Commitments
Concentration
Converitble Note Payable, Related Party
—
Convertible Note Related Party
—
Cybersecurity Risk Management and Strategy Disclosure
—
Furniture, Fixtures and Equipment
—
Going Concern and Liquidity
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Intangibles, Net
—
Inventories
Note 1
—
Note 10
—
Note 11
—
Note 12
—
Note 13
—
Note 14
—
Note 2
—
Note 2- Liquidity and Uncertainties
—
Note 3
—
Note 4
—
Note 5
—
Note 6
—
Note 7
—
Note 8
—
Note 9
—
Note A
—
Note B
—
Note C
—
Note D
—
Note E
—
Note F
—
Note G
—
Note H
—
Note I
—
Note J
—
Note K
—
Note L
—
Note M
—
Note N
—
Note O
—
Note P
—
Note Q
—
Organization and Business
Pay Vs Performance Disclosure
Recovery of Erroneously Awarded Compensation
—
Related Party Transactions
Segment and Geographic Data
Stock Option Plans
Stockholders Equity
Subsequent Event
Summary of Significant Accounting Policies